Chronic lymphocytic leukemia (CLL) is a type of cancer affecting a type of white blood cell in the blood and bone marrow. It ...

CLL affects B lymphocytes, or B cells, which help your body fight infections. Most people who receive a diagnosis of CLL experience few or no symptoms. A doctor may only suspect CLL when the ...

A study in Cancer compared the accuracy of five risk scores for time to treatment in CLL, including the IPS-E, CR0, AIPS-E, ...

If your doctor suspects you have CLL, they may use various tests to confirm the diagnosis. For example, they’ll probably order one or more of the following tests. Experts don’t exactly know ...

Roche/AbbVie’s cancer drug venetoclax, which is set to become standard of care in chronic lympocytic leukaemia, could further improve prognosis ... (rituximab) in CLL, compared with standard ...

The following is a summary of "BCL-2 dependence is a favorable predictive marker of response to therapy for chronic ...

IGHV mutations: key factor in determining the prognosis of chronic lymphocytic leukemia. Eastern Cooperative Oncology Group performance-status score: ranging from 0 to 5, with higher scores indicating ...

Based on this prognosis, mimicmiR-15, mimicmiR-16 and/or mimicmiR-29 (yet to be developed), coupled to a B-cell-specific ligand, would be a promising approach against good CLL and/or aggressive ...

If you have a loved one with CLL, you’ll want to know how best to help them. Here’s what you should know about treatments, support, and more.

BRUIN CLL-321 serves as the confirmatory trial to ... The study population had poor-prognosis disease, with 54% harboring 17p deletions and/or TP53 mutations, and over 60% with complex karyotype.